Kallistatin in follicular fluid of women with endometriosis and its correlation with IVF outcome

Observational OA: closed CC0
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

Endometriosis patients had lower kallistatin levels in follicular fluid, correlating with reduced IVF success rates, suggesting kallistatin may predict IVF-ET outcomes.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-11-10 · read from full text ⓘ

This study measured kallistatin concentrations in the follicular fluid of 40 women with endometriosis and 40 controls undergoing IVF to assess correlations with reproductive outcomes. The results demonstrated that patients with endometriosis had significantly lower kallistatin levels compared to the control group, alongside reduced rates of fertilization, available embryos, and top-quality embryo formation. Furthermore, higher kallistatin concentrations were associated with successful clinical pregnancy across both groups, suggesting its potential as a predictive marker for IVF success. This paper is centrally about endometriosis — specifically investigating the molecular mechanisms linking the condition to impaired oocyte quality and poor assisted reproductive technology outcomes.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

BACKGROUND: Endometriosis (EM) affects 10% women of reproductive age and alters fertility. Its management is still debated notably the timing of surgery and ART in infertility. Kallistatin (KS) is an endogenous protein that regulates differential signaling pathways and biological functions. However, the function and the underlying molecular mechanism in EM and its correlation with in vitro fertilization (IVF) outcome have not been determined. The purpose of this study was to evaluate KS concentrations in follicular fluid (FF) of women with EM and controls women without EM who underwent IVF with embryo transfer (IVF-ET). METHODS: FF KS concentrations from 40 patients with EM and 40 non-EM patients were measured by ELISA. RESULTS: Compared with the non-EM patients, patients with EM had lower KS levels in FF (281.67 ± 104.60 vs. 490.70 ± 216.33 pg/ml). The rates of fertilization (61.64 ± 22.42 vs. 71.00 ± 24.39%), available embryo (45.96 ± 19.83 vs. 50.61 ± 26.26%), and top-quality embryo (12.71 ± 21.01 vs. 16.04 ± 16.87%) were significantly lower in the EM group than in the control group. The KS concentrations in the FF of women who conceived consequent to the treatment were significantly higher than those from women who did not in the combined EM and control groups. CONCLUSIONS: These results indicate that the KS concentration in FF could be used as a predictor for IVF-ET outcomes. This may contribute to the pathologic mechanism responsible for the poor outcome of IVF in patients with EM.
Full text 20,371 characters · extracted from oa-pdf · 13 sections · click to expand

Keywords

Endometriosis; Kallistatin; follicular uid; IVF outcome Posted Date: January 9th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-140378/v1 License:   This work is licensed under a Creative Commons Attribution 4.0 International License.   Read Full License Version of Record: A version of this preprint was published at Gynecological Endocrinology on July 8th, 2021. See the published version at https://doi.org/10.1080/09513590.2021.1928067. Page 2/11

Abstract

Background: Endometriosis (EM) affects 10% of women in reproductive age and alters fertility. Its management is still debated notably the timing of surgery and ART in infertility. Kallistatin (KS) is an endogenous protein that regulates differential signaling pathways and biological functions. However, the function and the underlying molecular mechanism in endometriosis and its correlation with IVF outcome have not been determined. The purpose of this study was to evaluate KS concentrations in follicular uid of women with EM and controls women without EM who underwent IVF with embryo transfer (IVF–ET).

Methods

Follicular uid KS concentrations from 40 patients with EM and 40 non-EM patients were measured by ELISA.

Results

Compared with the non-EM patients, patients with EM had lower KS levels in follicular uid (281.67±104.60 pg/ml vs. 490.70 ±216.33pg/ml). The rates of fertilization(61.64±22.42% vs. 71.00±24.39%) , available embryo (45.96±19.83% vs.50.61±26.26%)  and top-quality embryo(12.71±21.01% vs.16.04±16.87%) were signicantly lower in the EM group than in the control group. The KS concentrations in the follicular uid of women who conceived consequent to the treatment were signicantly higher than those from women who did not in the combined EM and control groups.

Conclusions

The present results indicate that the KS concentration in follicular uid could be used as a predictor for IVF–ET outcomes. This may contribute to the pathologic mechanism responsible for the poor outcome of IVF in patients with EM.

Background

Endometriosis is a common chronic gynecologic disorder dened by the ectopic occurrence of endometrium-like tissue which is associated with pelvic pain and infertility[1]. It has been estimated at 10% in women of reproductive age[2]. The causes of infertility in women with endometriosis may range from anatomical distortions due to adhesions and brosis to abnormalities and immunological disturbances[3, 4]. Approximately 25–50% of infertile women have EM, and 30–50% of women with EM are infertile[5]. Assisted reproductive technology (ART) may be required with endometriosis-related infertility. Accumulating evidence suggests that EM affects oocyte and embryo development as well as endometrial receptivity, resulting in poor in vitro fertilization (IVF) outcomes[6-10]. However, the mechanism is unclear.  Follicular fuid (FF) provides an environment that controls oocyte growth and maturation, and plays a key role in ovulation, subsequent fertilization and early embryo development[11]. Both cellular and secreted mediators are aberrantly expressed in the peritoneal fuid (PF) and plasma of EM patients[12]. Some studies have shown that angiogenesis and tissue growth factor are increased in the serum and PF of women with EM[13, 14]. Page 3/11 For these reasons, we analyzed the concentrations of KS in the FF of women undergoing IVF to identify factors related to EM and to further elucidate its correlation with IVF outcome. KS is an endogenous protein that regulates differential signaling pathways and biological functions inhibiting inammation, angiogenesis, oxidative stress, apoptosis, tumor growth and metastasis in animal models and cultured cells[15-22]. Plasma levels of KS are reduced in patients with sepsis, liver disease and obesity[23, 24]. Our preliminary data showed that KS in EM patients’ endometrial tissue and blood were much lower than control patients without endometriosis and the decrease of KS is correlated with the severity of endometriosis. However, the concentrations of KS in the follicular uid of EM patients and its correlation with IVF outcome have not been determined. The aim of this study was to investigate KS in follicular uid of women with endometriosis and its correlation with IVF outcome. This information may form the basis of strategies to control these factors and improve the IVF outcomes in patients with EM.

Methods

Subjects A total of 80 patients who underwent IVF-ET between July 2017 and August 2018 in the Center for Reproductive Medicine, Third Aliated Hospital of Guangzhou Medical University, were recruited for this study. The study population consisted of Forty women with EM and 40 women without EM. The presence or absence of endometriosis was con fi rmed by laparoscopic surgery and post-operative histological examination. Women with polycystic ovary syndrome, diabetes, hypertension, dyslipidemia, HIV infection or any active infection and autoimmune diseases were excluded. Follicular uid (FF) was extracted from both groups. ART procedures Women were monitored and managed according to the hospital’s clinical protocols. Various controlled ovarian stimulation (COS) protocols were used, with 150-450 IU/day of recombinant FSH or human menopausal gonadotropin in a gonadotropin-releasing hormone antagonist protocol, a long agonist protocol, or a short agonist protocol. The protocols were determined according to each patient's characteristics (age, body mass index (BMI), AFC and AMH). Transvaginal oocyte retrieval was scheduled 35-36 h after hCG injection ART was performed per standard operating procedure of the hospital. Fertilization was assessed by the appearance of two pronuclei. Cleavage stage embryos were graded as per the Istanbul consensus. Fresh embryo transfer (ET) was performed 2-3 or 5 days later. Embryos were vitried frozen on day 3,5 or 6. The luteal phase was supported by vaginal administration of micronized progesterone (400 mg/d) started on the day of ovarian puncture. Follicular uid collection Page 4/11 Follicular uid was preserved at oocyte retrieval, by collecting the liquid aspirated from the follicle into the suction tube, to avoid contamination by blood. Follicular uid samples from each follicle were pooled for each patient for measurement of KS concentrations. Pooled follicular uid was centrifuged at 1500g for 10 min to eliminate cells and cell debris. And the supernatants were then stored at -20°C for KS concentration measurements. KS and hormone assays The follicular uid KS concentrations were collected and determined measured by enzyme-linked immunosorbent assay (human kallistatin ELISA kits, Catalog Number: DY1669; R&D Systems, USA) according to the manufacturer's protocol. The concentrations of serum oestradiol, FSH, LH, progesterone, testosterone and AMH, and follicular uid oestradiol and progesterone, were measured by chemiluminescence (Roche, Switzerland). Outcome measure The reproductive outcome of this study included implantation, clinical pregnancy, live birth rate (LBR) and spontaneous miscarriage rates. Neonatal outcomes included preterm birth, stillbirth, birth weight, low birth weight and congenital anomalies. Live birth was dened as the delivery of any viable neonate who was 28 weeks of gestation or older, and twins delivered by one mother were calculated as one live birth. Clinical pregnancy was dened as the present of gestational sac on ultrasound at 6-8 weeks of gestation; low birth weight was dened as the birth weight less than 2500 g and very low birth weight less than 1500 g. Statistical analysis The statistical analysis was performed using the Statistical Package for Social Science (SPSS) version 22.0. The baseline characteristic was expressed as the mean ± SD (standard deviation) and differences in variables were compared by means of Student’s t-test. Categorical variables were described as frequencies and percentages, and compared using chi-square test. A P-value of 0.05 was considered signicant.

Results

Patient characteristics  Eighty women were selected. Baseline characteristics of these women are shown in Table 1. No signicant differences were observed between the EM and control groups regarding age, body mass index and duration of sterility. In the control group, there were 4 patients with infertility due to tubal factor (10%), two cases of ovulatory dysfunction (5%), 20 cases of male factor (50%), 14 cases of unexplained (35%).30 patients in the control group were given IVF protocols, while 10 underwent ICSI procedures. In EM group, IVF protocols were given to 70% women and 30% underwent ICSI procedures. Page 5/11 KS expression was decreased in FF of EM patients Serum concentration of base LH, FSH, Progesterone(P), Testosterone(T), E2 and AMH showed no difference between the EM and control groups. Moreover, The FF KS concentrations in the EM patients were 281.67±104.60 pg/ml and lower than those in the control group (490.70 ±216.33pg/ml) (P < 0.05) (Table 2). ART Cycle Characteristics in EM and control subjects. Comparisons of ART Cycle Characteristics between the EM and control groups were summarized in Table 3. The AFC, Dosage of Gn, Endometrial thickness, No. of embryos retrieved, the rates of cleavage and No. of embryos transferred were similar among between the two FET groups. Meanwhile, the rates of fertilization, available embryo and top-quality embryo were signicantly lower in the EM group than in the control group. KS concentrations in follicular uid from subjects with different pregnancy outcomes The clinical pregnancy rate in the EM group was 61.54% (24/39), which was signicantly lower than that in the control group (67.57%, 25/37). In both the EM (Figure 1B) and control groups (Figure 1A), the KS concentrations in the follicular uid of women who conceived consequent to the treatment were signicantly higher than those in women who did not. The KS concentrations in the follicular uid of women who conceived consequent to the treatment were signicantly higher than those from women who did not in the combined EM and control groups (P < 0.05; Figure 1C). To evaluate the potential of KS concentrations in the follicular uid for predicting clinical pregnancy, receiver operating characteristic (ROC) curves were plotted, and the area under the curve (AUC) values were determined with the highest specicity and sensitivity set as the optimal prediction point (Figure 1D). Optimal prediction point, sensitivities, specicities and AUC values were 292.78 pg/ml, 71.7%, 65% and 0.7279, respectively. The present results indicate that the KS concentration in follicular uid could be used as a predictor for IVF– ET outcomes.

Discussion

FF composition is complex and is basically derived from plasma exudation and ovarian secretion[25]. It is an important environment for oocyte survival and directly affects oocyte maturation and quality. FF contains a large number of cytokines, a variety of hormones, oxidation/ antioxidant systems and metabolic products [13]. In this study, analysis of the levels of KS in follicular uid of women with EM and controls women without EM who underwent IVF with embryo transfer (IVF–ET). Data clearly show thatcompared with the non-EM patients, patients with EM had lower KS levels in follicular uid. This indicates that low KS concentrations in follicular uid may play a key role in folliculogenesis and the pathogenesis of EM. However, there were no differences in the concentrations of LH FSH P T E2 and AMH between the EM and control groups. Page 6/11 This means that the KS changes of follicular microenvironment caused by EM are independent of these six factors. KS is an endogenous protein that regulates differential signaling pathways and biological functions. Our preliminary data showed that KS in EM patients’ endometrial tissue and blood were much lower than control patients without endometriosis and the decrease of KS is correlated with the severity of endometriosis. However, the concentrations of KS in the follicular uid of EM patients and its correlation with IVF outcome have not been determined. This study found that the rates of fertilization, available embryo and top-quality embryo were signicantly lower in the EM group than in the control group. This

Result

is consistent with the worse prognosis of EM reported in previous literature. We supposed that KS can signicantly improve the quality of oocytes and embryos. However, whether KS can act as a biomarker for predicting the clinical pregnancy of EM remain unknown. ROC curves were plotted in our study, result showed that the area under the curve (AUC) values was 0.7279. The present results indicate that the KS concentration in follicular uid could be used as a predictor for IVF–ET outcomes. Based on the ndings of our study, we conclude that KS is associated with the microenvironment of FF in patients with EM. The change in the regulation network in EM inuence oocyte development, resulting in poor IVF outcomes. However, the results in this study should be validated in a large sample in the future.

Conclusion

Our study provides a theoretical basis for the development of strategies to improve the outcome of IVF in patients with EM. This evidence may help to clarify the pathology of EM and seek new treatments for EM patients. Abbreviations Endometriosis                        EM Kallistatin                           KS in vitro fertilization               IVF peritoneal fuid                   PF Follicular fuid                   FF controlled ovarian stimulation      COS body mass index                 BMI live birth rate                    LBR Page 7/11 area under the curve              AUC luteinizing hormone               LH Follicle-Stimulating Hormone       FSH progesterone                     P testosterone                      T estrogen                        E2 Anti-mullerian hormone           AMH   Declarations Ethical Approval and Consent to participate This study was approved by the ethics committee of the Third Aliated Hospital of Guangzhou Medical University. Consent for publication Not applicable. Availability of supporting data The data sets used and/or analyzed during the current study are available from the corresponding author on reasonable request. Competing interests The authors have declared that no conict of interest exists. Funding This study was supported by National Nature Science Foundation of China, Grant Numbers: 81871211 Authors' contributions All authors have contributed signicantly to this manuscript and each author has contributed to the manuscript as follows: Yuling Mao and Rui Chen designed the project. Yuling Mao, Shaoquan Zhan collected clinical samples and performed the ELISA experiments. Jingda Qiao and Lei Li analyzed the data. Yuling Mao wrote the manuscript. Hanyan Liu and Rui Chen revised the manuscript. All authors Page 8/11 read and approved the nal manuscript.

Acknowledgements

The study was performed under the auspices of the IVF unit of the Third Aliated Hospital of Guangzhou Medical University.

References

1. Gordts S, Koninckx P, Brosens I. Pathogenesis of deep endometriosis. Fertil Steril. 2017;108(6):872– 85 e1. 2. Meuleman C, et al. High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners. Fertil Steril. 2009;92(1):68–74. 3. Senapati S, et al. Impact of endometriosis on in vitro fertilization outcomes: an evaluation of the Society for Assisted Reproductive Technologies Database. Fertil Steril. 2016;106(1):164–71 e1. 4. Vercellini P, et al. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10(5):261– 75. 5. Du YB, et al. Endocrine and inammatory factors and endometriosis-associated infertility in assisted reproduction techniques. Arch Gynecol Obstet. 2013;287(1):123–30. . Da Broi MG, et al. Oocyte oxidative DNA damage may be involved in minimal/mild endometriosis- related infertility. Mol Reprod Dev. 2018;85(2):128–36. 7. Garrido N, et al. The endometrium versus embryonic quality in endometriosis-related infertility. Hum Reprod Update. 2002;8(1):95–103. . Barnhart K, Dunsmoor-Su R, Coutifaris C. Effect of endometriosis on in vitro fertilization. Fertil Steril. 2002;77(6):1148–55. 9. Freis A, et al. Relative Morphokinetics Assessed by Time-Lapse Imaging Are Altered in Embryos From Patients With Endometriosis. Reprod Sci. 2018;25(8):1279–85. 10. Sanchez AM, et al., Is the oocyte quality affected by endometriosis? A review of the literature. Journal of Ovarian Research, 2017. 10. 11. Da Broi MG, et al. Inuence of follicular uid and cumulus cells on oocyte quality: clinical implications. J Assist Reprod Genet. 2018;35(5):735–51. 12. Miller JE, et al. Implications of immune dysfunction on endometriosis associated infertility. Oncotarget. 2017;8(4):7138–47. 13. Taylor RN, Lebovic DI, Mueller MD, Angiogenic factors in endometriosis. Ann N Y Acad Sci, 2002. 955: p. 89–100; discussion 118, 396–406. 14. Deguchi M, et al. Expression of angiogenic factors in extrapelvic endometriosis. Oncol Rep. 2001;8(6):1317–9. 15. Chao J, et al. Kallistatin, a novel human tissue kallikrein inhibitor: levels in body uids, blood cells, and tissues in health and disease. J Lab Clin Med. 1996;127(6):612–20. Page 9/11 1. Zhu H, et al. Plasma kallistatin is associated with adiposity and cardiometabolic risk in apparently healthy African American adolescents. Metabolism. 2013;62(5):642–6. 17. Miao RQ, et al. Structural elements of kallistatin required for inhibition of angiogenesis. Am J Physiol Cell Physiol. 2003;284(6):C1604-13. 1. Shen B, et al. Kallistatin attenuates endothelial apoptosis through inhibition of oxidative stress and activation of Akt-eNOS signaling. Am J Physiol Heart Circ Physiol. 2010;299(5):H1419–27. 19. Shen B, et al. Salutary effect of kallistatin in salt-induced renal injury, inammation, and brosis via antioxidative stress. Hypertension. 2008;51(5):1358–65. 20. Wang CR, et al. Prophylactic adenovirus-mediated human kallistatin gene therapy suppresses rat arthritis by inhibiting angiogenesis and inammation. Arthritis Rheum. 2005;52(4):1319–24. 21. Yin H, et al. Kallistatin inhibits vascular inammation by antagonizing tumor necrosis factor-alpha- induced nuclear factor kappaB activation. Hypertension. 2010;56(2):260–7. 22. Shiau AL, et al. Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin. BMC Cancer. 2010;10:245. 23. Gao L, et al. Role of kallistatin in prevention of cardiac remodeling after chronic myocardial infarction. Lab Invest. 2008;88(11):1157–66. 24. Miao RQ, et al. Kallistatin is a new inhibitor of angiogenesis and tumor growth. Blood. 2002;100(9):3245–52. 25. Kollmann Z, et al. Gonadotrophin stimulation in IVF alters the immune cell prole in follicular uid and the cytokine concentrations in follicular uid and serum. Hum Reprod. 2017;32(4):820–31. Tables Due to technical limitations, table 1 to 3 is only available as a download in the Supplemental Files section. Figures Page 10/11 Figure 1 KS concentrations in women who conceived consequent to the treatment (Pregnancy) and women who did not (Non-pregnancy). (A) KS concentrations in follicular uid of control women in women who conceived consequent to the treatment and those who did not. (B) KS concentrations in follicular uid of EM patients who conceived consequent to the treatment and those who did not. (C) KS concentrations in follicular uid of all women who conceived consequent to the treatment and women who did not. (*P < 0.05). (D) ROC curve analysis to assess the predictive powers of clinical pregnancy. Page 11/11 Supplementary Files This is a list of supplementary les associated with this preprint. Click to download. table1.jpg table2.jpg table3.jpg

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-pdf ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisinfertility

MeSH descriptors

Endometriosis Fertilization in Vitro Follicular Fluid Serpins Adult Adult Case-Control Studies Case-Control Studies Endometriosis Endometriosis Female Female Fertilization in Vitro Fertilization in Vitro Follicular Fluid Follicular Fluid Humans Humans Pregnancy Pregnancy

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (25)

Source provenance

europepmc
last seen: 2026-11-21T06:17:04.340742+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:31:40.936856+00:00
unpaywall
last seen: 2026-07-04T06:30:40.387034+00:00
License: CC0 · commercial use OK